Professor and Chair of Psychiatry, Stony Brook University
Psychiatry
Dr. Ramin V. Parsey, MD
|
|
Give Review
Ramin Parsey works in the field of Psychiatry. He studied medicine at University of Maryland School of Medicine. University of Maryland School of Medicine is ranked 37 in research and 52 in primary care medicine Doctor Ramin V. Parsey, MD is a published doctor and has 101 publications published. The lastest was: 'The 5-HT1A receptor in Major Depressive Disorder.'
Publications
- The 5-HT1A receptor in Major Depressive Disorder.
- Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder.
- Quantification of the Serotonin 1A Receptor Using PET: Identification of a Potential Biomarker of Major Depression in Males.
- Estimation of in vivo nonspecific binding in positron emission tomography studies without requiring a reference region.
- Noninvasive blood-free full quantification of positron emission tomography radioligand binding.
- In Vivo Ketamine-Induced Changes in [(11)C]ABP688 Binding to Metabotropic Glutamate Receptor Subtype 5.
- Quantifying serotonin transporters by PET with [(11) C]-DASB before and after interferon-αtreatment.
- A diffusion tensor imaging study of suicide attempters.
- Genetic Variation in Brain-Derived Neurotrophic Factor val66met Allele is Associated with Altered Serotonin-1A Receptor Binding in Human Brain.
- Cortical thickness differences between bipolar depression and major depressive disorder.
- Higher pretreatment 5-HT1A receptor binding potential in bipolar disorder depression is associated with treatment remission: a naturalistic treatment pilot PET study.
- Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an i...
- Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder.
- Brain Serotonin 1A Receptor Binding as a Predictor of Treatment Outcome in Major Depressive Disorder.
- Prediction of selective serotonin reuptake inhibitor response using diffusion-weighted MRI.
- Imaging the serotonin 1A receptor using [11C]WAY100635 in healthy controls and major depression.
- Autoradiographic evaluation of [(3)H]CUMI-101, a novel, selective 5-HT1AR ligand in human and baboon brain.
- Positron Emission Tomography Quantification of Serotonin Transporter in Suicide Attempters with Major Depressive Disorder.
- Reference region approaches in PET: a comparative study on multiple radioligands.
- HIGHER IN VIVO SEROTONIN-1A BINDING IN POSTTRAUMATIC STRESS DISORDER: A PET STUDY WITH [(11) C]WAY-100635.
- Synthesis and in vivo evaluation of [O-methyl-11C] N-[3,5-dichloro-2-(methoxy)phenyl]-4-(methoxy)-3-(1-piperazinyl)benzenesulfonamide as an imaging probe for 5-HT6 rec...
- In vivo variation in metabotropic glutamate receptor subtype 5 binding using positron emission tomography and [11C]ABP688.
- Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior.
- Plasma A? and PET PiB binding are inversely related in mild cognitive impairment.
- SEP-225289 serotonin and dopamine transporter occupancy: a PET study.
- In vivo positron emission tomography imaging with [¹¹C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons.
- Ex vivo evaluation of the serotonin 1A receptor partial agonist [³H]CUMI-101 in awake rats.
- In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer.
- Serotonin receptor imaging: clinically useful?
- (99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.
- In vivo serotonin-sensitive binding of [11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer.
- Synthesis and in vivo evaluation of [11C]MPTQ: a potential PET tracer for alpha2A-adrenergic receptors.
- Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations.
- Synthesis, in vitro and in vivo evaluation of [11C]MMTP: a potential PET ligand for mGluR1 receptors.
- Empirical Bayesian estimation in graphical analysis: a voxel-based approach for the determination of the volume of distribution in PET studies.
- Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controls.
- Regional brain metabolic correlates of self-reported depression severity contrasted with clinician ratings.
- PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
- Evaluation of volume-based and surface-based brain image registration methods.
- Simultaneous estimation of input functions: an empirical study.
- Safety of radial arterial catheterization in PET research subjects.
- Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.
- Modeling considerations for in vivo quantification of the dopamine transporter using [(11)C]PE2I and positron emission tomography.
- Nucleotide variation in central nervous system genes among male suicide attempters.
- Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.
- Reported childhood abuse is associated with low serotonin transporter binding in vivo in major depressive disorder.
- Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression.
- 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.
- Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration.
- Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression.
- Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease.
- Effect of BDNF val66met polymorphism on age-related amygdala volume changes in healthy subjects.
- Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET.
- Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.
- Family history of suicidal behavior and early traumatic experiences: additive effect on suicidality and course of bipolar illness?
- Whole body [11C]-dihydrotetrabenazine imaging of baboons: biodistribution and human radiation dosimetry estimates.
- Quantitative wavelet domain image processing of dynamic PET data.
- Biodistribution and radiation dosimetry of 11C-harmine in baboons.
- Consensus nomenclature for in vivo imaging of reversibly binding radioligands.
- Optimal metabolite curve fitting for kinetic modeling of 11C-WAY-100635.
- PET Imaging of CRF1 with [11C]R121920 and [11C]DMP696: is the target of sufficient density?
- Positron emission tomography study of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without comorbid lifetime al...
- Does first episode polarity predict risk for suicide attempt in bipolar disorder?
- What have we learned about the neurobiology of major depression?
- Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography.
- Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl- 11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3...
- In vivo assessment of [11C]MRB as a prospective PET ligand for imaging the norepinephrine transporter.
- Synthesis and in vivo evaluation of [18F]-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide as a PET imaging probe for COX-2 expression.
- In vitro and in vivo evaluation of [11C]MPEPy as a potential PET ligand for mGlu5 receptors.
- Metabolite considerations in the in vivo quantification of serotonin transporters using 11C-DASB and PET in humans.
- In vivo quantification of serotonin transporters using [(11)C]DASB and positron emission tomography in humans: modeling considerations.
- Synthesis and in vivo evaluation of [O-methyl-11C](2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy)phenyl]ethyl]phenoxy]ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand.
- Synthesis and in vivo evaluation of [11C]SN003 as a PET ligand for CRF1 receptors.
- Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: a novel agonist 5-...
- Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study.
- Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A recept...
- Lower serotonin transporter binding potential in the human brain during major depressive episodes.
- Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain.
- Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography.
- Amyloid plaque imaging agent [C-11]-6-OH-BTA-1: biodistribution and radiation dosimetry in baboon.
- Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study.
- Brain serotonin1A receptor binding in major depression is related to psychic and somatic anxiety.
- Biodistribution and radiation dosimetry of 11C-WAY100,635 in humans.
- Neuroanatomic correlates of psychopathologic components of major depressive disorder.
- Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality dis...
- Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography.
- Biodistribution and radiation dosimetry of [11C]DASB in baboons.
- Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency.
- Regional brain responses to serotonin in major depressive disorder.
- Regional brain gray matter volume differences in patients with bipolar disorder as assessed by optimized voxel-based morphometry.
- Synthesis of [O-methyl-11C]1-(2-chlorophenyl)-5-(4-methoxyphenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide: a potential PET ligand for CB1 receptors.
- Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression.
- OS-EM and FBP reconstructions at low count rates: effect on 3D PET studies of [11C] WAY-100635.
- Determination of volume of distribution using likelihood estimation in graphical analysis: elimination of estimation bias.
- Applications of positron emission tomography in psychiatry.
- Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression.
- Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635.
- Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression.
- Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography ...
- In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652.
Schools
University of Maryland At Baltimore Professional Schools
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
Duke University Hospital -
University of Maryland School of Medicine
Hospital
-
Stony Brook University Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Claire H. Kim, DO |
|
|
Dr. Milena Goldshmidt, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry M. Fourcade, MD |
|
|
Dr. Mehak Chopra, DO |
|
|
Dr. Lisa M. Bonvino, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reena Baharani, MD |
|
|
Dr. Lama R. Bazzi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin C. Delucia, MD |
|
|
Dr. Ashraf H. Abaza, MD |